相关实验视频

Updated: Aug 7, 2026

High Throughput Screening of Fungal Endoglucanase Activity in Escherichia coli
06:16

High Throughput Screening of Fungal Endoglucanase Activity in Escherichia coli

Published on: August 13, 2011

20.6K

使用基于PNP的试剂选新型葡萄糖乙酶的高效活性选

Michael S Madsen1, Pedro A Martins1, Jane W Agger1

  • 1Technical University of Denmark, Lignin Biotechnology, Department of Biotechnology and Biomedicine, Søltofts Plads 224, Kgs Lyngby DK-2800, Denmark.

Enzyme and microbial technology
|April 6, 2024
PubMed
概括

研究人员选了15种真菌葡萄糖乙酶 (CE15) 进行菌纤维素加工. 七种酶表现出活性,其中活性候选物来自Auricularia subglabra,Ganoderma sinensis和Neocallimastix californiae.

关键词:
活动选活动选CE15 CE15 CE15 CE15 CE15 CE15 CE15 CE15 CE15 CE15葡萄糖烯酸乙酶是葡萄糖烯酸乙酶.红素碳水化合物复合物 红素碳水化合物复合物再组合的表达方式.具体活动 具体活动 具体活动

更多相关视频

Determination of Microbial Extracellular Enzyme Activity in Waters, Soils, and Sediments using High Throughput Microplate Assays15:23

Determination of Microbial Extracellular Enzyme Activity in Waters, Soils, and Sediments using High Throughput Microplate Assays

Published on: October 1, 2013

39.0K
Multi-enzyme Screening Using a High-throughput Genetic Enzyme Screening System08:10

Multi-enzyme Screening Using a High-throughput Genetic Enzyme Screening System

Published on: August 8, 2016

8.8K

相关概念视频

Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Oral Hypoglycemic Agents: Glinides01:06

Oral Hypoglycemic Agents: Glinides

Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively manages...
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...